Showing 1 - 5 results of 5 for search 'Antonio Garcia-Guiñon', query time: 0.03s Refine Results
  1. 1
    PB2123: ROLE OF INTERLEUKIN 6 AND ANGIOPOIETINS 1 AND 2 IN THE EVOLUTION OF PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA

    PB2123: ROLE OF INTERLEUKIN 6 AND ANGIOPOIETINS 1 AND 2 IN THE EVOLUTION OF PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA by Rosa Isabel Upegui, Antonio Garcia-Guiñon, Xavier Gómez Arbonés

    Published 2023-08-01
    Get full text
    Article
  2. 2
    S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB

    S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE... by Juan Miguel Bergua Burgues, Rebeca Rodríguez-Veiga, Isabel Cano Ferri, Ferran Vall-Llovera Calmet, Antonio Garcia-Guiñon, Joaquin Gomez Espuch, Mercedes Colorado, Ignacio Casas-Avilés, Jordi Esteve, Antonia Sampol, Maria Victoria Verdugo, Fernando Ramos, Marta Valero, Evelyn Gloria Acuña Cruz, Blanca Boluda, Laura Torres Miñana, Joaquín Martinez-Lopez, Eva Barragan, Rosa Ayala Diaz, David Martinez-Cuadrón, Pau Montesinos

    Published 2023-08-01
    Get full text
    Article
  3. 3
    P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP.

    P937: CARFILZOMIB, LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: UPDATE ANALYSIS OF REAL-LIFE EXPERIENCE OF GEMMAC GROUP. by Antonio Garcia-Guiñon, Paola Andrea Charry, Maria Moraima Jimenez, Jose Sarra Escarre, Izarbe Delgado, Laura Segura de la Torre, Marta Santaliestra Tomas, Marta Garcia Pintos, Yolanda Gonzalez Montes, Maria Alicia Senin Magan, Cristina Motllo, Randa Ben Azaiz, Maria Elena Cabezudo, Miquel Granell Gorrochategui, Esther Sancho, Maria Jose Herranz, Yasmina Seres, Mercedes Gironella, Juan A Soler, Jose Maria Marti Tutusaus, Eugenia Abella Monreal, Carlos Fernandez de Larrea

    Published 2023-08-01
    Get full text
    Article
  4. 4
    P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3-ITD MUTATED AML

    P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3-ITD MUTATED AML by Mar Tormo, Marina Diaz-Beya, Paola Beneit, Ainhoa Fernández Moreno, Montserrat Arnan, Ana Garrido Diaz, Susana Vives, Maria García Fortes, Antonia Sampol, Jorge Labrador, Antonio Garcia-Guiñon, Carmen Botella, Juan Miguel Bergua Burgues, Mayte Olave, Maria Luz Amigo, Xavier Ortín, Ferrand Ferran Vall-Llovera, Maria Pereiro, Josefina Serrano, Maria Jose Sayas Lloris, Almudena De Laiglesia Lorenzo, Juan Jose Bargay Lleonart, Maria Luisa Calabuig Muñoz, Adolfo De La Fuente

    Published 2023-08-01
    Get full text
    Article
  5. 5
    P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL

    P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL by Josep Maria Ribera, Mireia Morgades, Olga García-Calduch, Maialen Sirvent, Buenaventura Buendía Ureña, Marta Cervera, Hugo Luzardo, Jesus Hernández Rivas, Marta Sitges Arriaga, Irene Garcia Cadenas, Pablo Abrisquet Acosta, Pau Montesinos, Mariana Bastos Oreiro, María-Paz Queipo de Llano, Pilar Bravo, Anna Torrent, Maria Pilar Herrera Puente, Antonio Garcia-Guiñon, Ferran Vall-Llovera Calmet, Josefina Serrano, Maria J Terol, Juan Miguel Bergua Burgues, Ana García-Noblejas, Cristina Barrenetxea, Laura Llorente, Daniel García-Belmonte, Eva Gimeno, Antonia Cladera, Santiago Mercadal Vilchez, Juan Manuel Sancho

    Published 2023-08-01
    Get full text
    Article

Search Tools: